8-K: CPSI Amends Credit Agreement and Reports Mixed 2023 Results, Announces TruBridge Rebrand

CPSI amended its credit agreement to address a covenant breach and reported its fourth quarter and full year 2023 financial results, while also announcing a rebrand to TruBridge.

Summary

• CPSI entered into a Fourth Amendment to its credit agreement, modifying the definition of Consolidated EBITDA and decreasing the Consolidated Fixed Charge Coverage Ratio covenant for 2024.
• The amendment allows for certain add-backs to Consolidated Net Income, including costs related to a voluntary early retirement program and specific fees, up to a combined limit of $7.25 million.
• The amendment also limits add-backs for cost savings related to the Viewgol acquisition to $6.6 million, but these savings are not subject to the 15% cap that applies to other savings.
• The Consolidated Fixed Charge Coverage Ratio was reduced from 1.25:1.00 to 1.15:1.00 for each fiscal quarter ending March 31, 2024 through December 31, 2024.
• CPSI received a one-time waiver for not complying with the Consolidated Fixed Charge Coverage Ratio as of December 31, 2023.
• CPSI reported fourth-quarter 2023 bookings of $26.0 million, compared to $24.7 million in the same period of 2022.
• Total revenue for the fourth quarter was $85.9 million, up from $83.2 million in the prior year's quarter.
• Revenue Cycle Management (RCM) revenue was $51.0 million, representing 60.7% of total recurring revenue and 59.3% of total revenue.
• The company reported a GAAP loss per diluted share of $(2.92) and non-GAAP earnings per diluted share of $0.36 for the fourth quarter.
• Adjusted EBITDA for the fourth quarter was $12.0 million, compared to $13.2 million in the fourth quarter of 2022.
• For the full year 2023, bookings were $85.1 million, compared to $89.4 million in 2022.
• Total revenue for 2023 was $339.4 million, up from $326.6 million in 2022.
• RCM revenue for the full year was $193.9 million, representing 58.9% of total recurring revenue and 57.1% of total revenue.
• The company reported a GAAP loss per diluted share of $(3.15) and non-GAAP earnings per diluted share of $1.79 for the full year.
• Adjusted EBITDA for the full year was $47.6 million, compared to $55.9 million in 2022.
• CPSI announced its imminent rebrand to TruBridge, reflecting its transformation and unified suite of solutions.
• The company provided a first-quarter 2024 outlook with revenue between $82 million and $84 million and adjusted EBITDA between $8.5 million and $9.5 million.
• The full-year 2024 outlook includes revenue between $340 million and $350 million and adjusted EBITDA between $45 million and $50 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company is showing some revenue growth and is making strategic moves like rebranding, the losses, decreased EBITDA, and credit agreement amendment raise concerns. The forward-looking guidance is positive, but the current financial performance is mixed.

Positives

• Fourth-quarter revenue increased year-over-year to $85.9 million.
• RCM revenue continues to be a strong contributor, representing a majority of total recurring revenue.
• The company is rebranding to TruBridge, which is intended to reflect a more cohesive and comprehensive suite of solutions.
• CPSI has provided a positive outlook for 2024, projecting revenue between $340 million and $350 million.
• The credit agreement amendment provides some flexibility in financial covenants.

Negatives

• CPSI reported a GAAP loss per diluted share of $(2.92) for the fourth quarter and $(3.15) for the full year.
• Adjusted EBITDA for both the fourth quarter and full year decreased compared to the prior year.
• The company was not in compliance with the Consolidated Fixed Charge Coverage Ratio as of December 31, 2023, requiring a waiver.
• Bookings for the full year 2023 were down compared to 2022, at $85.1 million versus $89.4 million.

Risks

• The company's substantial indebtedness and ability to incur additional debt could impact future operations.
• Restrictive terms of the credit agreement could limit current and future operations.
• The company faces competition from companies with greater financial, technical, and marketing resources.
• There is a risk of failure to develop new products or enhance current products to keep pace with market demands.
• The company is exposed to potential litigation and breaches of security in its systems.
• The company's financial performance is subject to fluctuations due to the timing of customer installations.
• Macroeconomic conditions, including bank failures, could have a material adverse effect.

Future Outlook

The company expects revenue between $82 million and $84 million and adjusted EBITDA between $8.5 million and $9.5 million for the first quarter of 2024. For the full year 2024, the company anticipates revenue between $340 million and $350 million and adjusted EBITDA between $45 million and $50 million.

Management Comments

• Chris Fowler, chief executive officer of CPSI, stated that despite challenges in 2023, the company finished the year with strong revenue performance.
• He also mentioned the imminent rebrand to TruBridge, reflecting the company's transformation and unified suite of solutions.
• Management believes that investments made to enhance the business will provide a strong foundation for growth.
• The company sees a significant opportunity to improve the financial health of community hospital partners and believes the Viewgol acquisition has strengthened its market position.

Industry Context

The healthcare industry is undergoing significant changes, including a shift towards value-based care and increased adoption of technology solutions. CPSI's rebrand to TruBridge and focus on RCM solutions align with these trends, aiming to provide a more comprehensive suite of services to its clients. The company's focus on community hospitals positions it within a specific niche of the healthcare market.

Comparison to Industry Standards

• CPSI's revenue growth of approximately 4% year-over-year is moderate compared to some high-growth technology companies in the healthcare sector, but is reasonable for a company focused on community hospitals.
• The company's adjusted EBITDA margin of 14% for the full year 2023 is lower than some of its larger competitors, such as Cerner (now Oracle Health) and Epic Systems, which typically have higher margins due to their scale and market dominance.
• The shift towards a subscription-based recurring revenue model is a common trend in the industry, and CPSI's focus on RCM aligns with this trend, similar to companies like R1 RCM and Optum.
• The company's bookings of $85.1 million for the full year 2023 are lower than some of its larger competitors, indicating a need to increase sales and market penetration.
• The company's focus on community hospitals is a niche market, and its performance should be compared to other companies serving similar markets, such as MEDITECH and Allscripts, which also have a significant presence in the community hospital space.

Stakeholder Impact

• Shareholders may be concerned about the reported losses and decreased EBITDA.
• Employees may be affected by the company's restructuring and rebrand.
• Customers may benefit from the company's unified suite of solutions under the TruBridge brand.
• Creditors may be reassured by the credit agreement amendment and the company's efforts to improve its financial position.

Next Steps

• The company will hold a live webcast to discuss fourth quarter and full year 2023 results.
• The company will continue to implement its rebrand to TruBridge.
• The company will focus on improving the financial health of its community hospital partners.
• The company will work to achieve its 2024 financial outlook.

Key Dates

Keywords

Credit Agreement, Consolidated EBITDA, Revenue Cycle Management, RCM, Healthcare Solutions, TruBridge, Financial Results, Adjusted EBITDA, Bookings, Rebranding